{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:11:08Z","timestamp":1784005868800,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12902-018-0263-1","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T12:14:46Z","timestamp":1528460086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany"],"prefix":"10.1186","volume":"18","author":[{"name":"on behalf of the German Society of Pediatric Endocrinology and Diabetology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-6737","authenticated-orcid":false,"given":"Helmuth G.","family":"D\u00f6rr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut A.","family":"Wollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold P.","family":"Hauffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Woelfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"issue":"6","key":"263_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/humupd\/dmh047","volume":"10","author":"MG Forest","year":"2004","unstructured":"Forest MG. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update. 2004;10(6):469\u201385.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"263_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32(1):81\u2013151.","journal-title":"Endocr Rev"},{"key":"263_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1196\/annals.1315.009","volume":"1038","author":"MI New","year":"2004","unstructured":"New MI. An update of congenital adrenal hyperplasia. Ann N Y Acad Sci. 2004;1038:14\u201343.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"263_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003;349(8):776\u201388.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"263_CR5","first-page":"72","volume":"10","author":"T Tajima","year":"2012","unstructured":"Tajima T, Fujikura K, Fukushi M, Hotsubo T, Mitsuhashi Y. Neonatal screening for congenital adrenal hyperplasia in Japan. Pediatr Endocrinol Rev. 2012;10(Suppl 1):72\u20138.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"Suppl 3","key":"263_CR6","doi-asserted-by":"publisher","first-page":"U71","DOI":"10.1530\/eje.0.151U071","volume":"151","author":"HJ van der Kamp","year":"2004","unstructured":"van der Kamp HJ, Wit JM. Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol. 2004;151(Suppl 3):U71\u20135.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"263_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrendo.2009.148","volume":"5","author":"PC White","year":"2009","unstructured":"White PC. Neonatal screening for congenital adrenal hyperplasia. Nat Rev Endocrinol. 2009;5(9):490\u20138.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"263_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/MED.0b013e328346938c","volume":"18","author":"CM Trapp","year":"2011","unstructured":"Trapp CM, Speiser PW, Oberfield SE. Congenital adrenal hyperplasia: an update in children. Curr Opin Endocrinol Diabetes Obes. 2011;18(3):166\u201370.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"263_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4419-8002-1_9","volume":"707","author":"PW Speiser","year":"2011","unstructured":"Speiser PW. Medical treatment of classic and nonclassic congenital adrenal hyperplasia. Adv Exp Med Biol. 2011;707:41\u20135.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"263_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nrendo.2010.197","volume":"7","author":"FG Riepe","year":"2011","unstructured":"Riepe FG. Adrenal gland: congenital adrenal hyperplasia: new treatment guidelines. Nat Rev Endocrinol. 2011;7(1):6\u20138.","journal-title":"Nat Rev Endocrinol"},{"key":"263_CR11","doi-asserted-by":"publisher","first-page":"656925","DOI":"10.1186\/1687-9856-2010-656925","volume":"2010","author":"R Padidela","year":"2010","unstructured":"Padidela R, Hindmarsh PC. Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2010;2010:656925.","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"263_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.beem.2008.10.010","volume":"23","author":"PC Hindmarsh","year":"2009","unstructured":"Hindmarsh PC. Management of the child with congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23(2):193\u2013208.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"263_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.05.004","volume":"132","author":"HL Claahsen-van der Grinten","year":"2011","unstructured":"Claahsen-van der Grinten HL, Stikkelbroeck NM, Otten BJ, Hermus AR. Congenital adrenal hyperplasia--pharmacologic interventions from the prenatal phase to adulthood. Pharmacol Ther. 2011;132(1):1\u201314.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"263_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1530\/EJE-15-0775","volume":"174","author":"B Odenwald","year":"2016","unstructured":"Odenwald B, Nennstiel-Ratzel U, Dorr HG, Schmidt H, Wildner M, Bonfig W. Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life. Eur J Endocrinol. 2016;174(2):177\u201386.","journal-title":"Eur J Endocrinol"},{"key":"263_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/EJE-12-0161","volume":"167","author":"N Reisch","year":"2012","unstructured":"Reisch N, Willige M, Kohn D, Schwarz HP, Allolio B, Reincke M, Quinkler M, Hahner S, Beuschlein F. Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur J Endocrinol. 2012;167:35\u201342.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"263_CR16","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","volume":"99","author":"H Falhammar","year":"2014","unstructured":"Falhammar H, Frisen L, Norrby C, Hirschberg AL, Almqvist C, Nordenskjold A, Nordenstrom A. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2014;99(12):E2715\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"263_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1542\/peds.29.1.3","volume":"29","author":"WW Cleveland","year":"1962","unstructured":"Cleveland WW, Green OC, Wilkins L. Deaths in congenital adrenal hyperplasia. Pediatrics. 1962;29:3\u201317.","journal-title":"Pediatrics"},{"issue":"3","key":"263_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1440-1754.1995.tb00790.x","volume":"31","author":"YJ Lim","year":"1995","unstructured":"Lim YJ, Batch JA, Warne GL. Adrenal 21-hydroxylase deficiency in childhood: 25 years' experience. J Paediatr Child Health. 1995;31(3):222\u20137.","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"263_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1651-2227.1990.tb11434.x","volume":"79","author":"A Thilen","year":"1990","unstructured":"Thilen A, Larsson A. Congenital adrenal hyperplasia in Sweden 1969-1986. Prevalence, symptoms and age at diagnosis. Acta Paediatr Scand. 1990;79(2):168\u201375.","journal-title":"Acta Paediatr Scand"},{"issue":"10","key":"263_CR20","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/clinchem\/44.10.2075","volume":"44","author":"N Krone","year":"1998","unstructured":"Krone N, Roscher AA, Schwarz HP, Braun A. Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency. Clin Chem. 1998;44(10):2075\u201382.","journal-title":"Clin Chem"},{"issue":"4","key":"263_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0022-3476(98)70060-5","volume":"133","author":"AJ Swerdlow","year":"1998","unstructured":"Swerdlow AJ, Higgins CD, Brook CG, Dunger DB, Hindmarsh PC, Price DA, Savage MO. Mortality in patients with congenital adrenal hyperplasia: a cohort study. J Pediatr. 1998;133(4):516\u201320.","journal-title":"J Pediatr"},{"issue":"2","key":"263_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1651-2227.2000.tb01213.x","volume":"89","author":"VR Jaaskelainen","year":"2000","unstructured":"Jaaskelainen VR. Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr. 2000;89(2):183\u20137.","journal-title":"Acta Paediatr"},{"issue":"1","key":"263_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1297\/cpe.12.19","volume":"12","author":"E Ogawa","year":"2003","unstructured":"Ogawa E, Fujieda K, Tachibana K, Inomata H, Kinoshita E, Kusuda S, Nishi Y, Okada T, Saisho S, Tajima T, et al. Mortaility in patients with congenital 21-.Hydroxylase deficiency diagnosed after the introduction of a newborn screening program in Japan. Clin Pediatr Endocrinology. 2003;12(1):19\u201323.","journal-title":"Clin Pediatr Endocrinology"},{"issue":"7","key":"263_CR24","first-page":"2958","volume":"86","author":"J Kovacs","year":"2001","unstructured":"Kovacs J, Votava F, Heinze G, Solyom J, Lebl J, Pribilincova Z, Frisch H, Battelino T, Waldhauser F. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab. 2001;86(7):2958\u201364.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"263_CR25","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJM200011093431903","volume":"343","author":"DP Merke","year":"2000","unstructured":"Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med. 2000;343(19):1362\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"263_CR26","first-page":"331","volume":"72","author":"F Tutunculer","year":"2009","unstructured":"Tutunculer F, Saka N, Arkaya SC, Abbasoglu S, Bas F. Evaluation of adrenomedullary function in patients with congenital adrenal hyperplasia. Horm Res. 2009;72(6):331\u20136.","journal-title":"Horm Res"},{"issue":"8","key":"263_CR27","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1210\/jc.2007-0493","volume":"92","author":"L Green-Golan","year":"2007","unstructured":"Green-Golan L, Yates C, Drinkard B, Van Ryzin C, Eisenhofer G, Weise M, Merke DP. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exercise. J Clin Endocrinol Metab. 2007;92(8):3019\u201324.","journal-title":"J Clin Endocrinol Metab"},{"issue":"45","key":"263_CR28","first-page":"739","volume":"106","author":"J Meyburg","year":"2009","unstructured":"Meyburg J, Bernhard M, Hoffmann GF, Motsch J. Principles of pediatric emergency care. Deutsches Arzteblatt Int. 2009;106(45):739\u201347. quiz 748","journal-title":"Deutsches Arzteblatt Int"},{"issue":"6","key":"263_CR29","doi-asserted-by":"publisher","first-page":"E925","DOI":"10.1210\/jc.2011-0015","volume":"96","author":"S Hsieh","year":"2011","unstructured":"Hsieh S, White PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab. 2011;96(6):E925\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"263_CR30","unstructured":"Von Petrykowski W, Abel M, Br\u00e4mswig J: Schweres Hirn\u00f6dem - eine wenig bekannte Manifestation des Glukokortikoidmangels. P\u00e4diatrische Praxis 1986\/87, 34:5."},{"issue":"1","key":"263_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1001\/archopht.1952.01700030089011","volume":"47","author":"FB Walsh","year":"1952","unstructured":"Walsh FB. Papilledema associated with increased intracranial pressure in Addison's disease. AMA. Arch Ophthalmol. 1952;47(1):86.","journal-title":"Arch Ophthalmol"},{"issue":"1985","key":"263_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.77.1985.58","volume":"77","author":"WW Swingle","year":"1933","unstructured":"Swingle WW, Pfiffner JJ, Vars HM, Bott PA, Parkins WM. The function of the adrenal cortical hormone and the cause of death from adrenal insufficiency. Science. 1933;77(1985):58\u201364.","journal-title":"Science"},{"key":"263_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3181\/00379727-119-30208","volume":"119","author":"WW Swingle","year":"1965","unstructured":"Swingle WW, Swingle AJ. Effect of adrenal steroids upon plasma volume of intact and Adrenalectomized dogs. Proc Soc Exp Biol Med. 1965;119:452\u20135.","journal-title":"Proc Soc Exp Biol Med"},{"key":"263_CR34","doi-asserted-by":"publisher","unstructured":"Salpietro V, Polizzi A, Di Rosa G, Romeo AC, Dipasquale V, Morabito P, Chirico V, Arrigo T, Ruggieri M. Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications. Int J Endocrinol 2014. 2014:282489. https:\/\/doi.org\/10.1155\/2014\/282489 .","DOI":"10.1155\/2014\/282489"},{"key":"263_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fped.2017.00213","volume":"5","author":"J Zieg","year":"2017","unstructured":"Zieg J. Pathophysiology of hyponatremia in children. Frontiers in Pediatr. 2017;5:213.","journal-title":"Frontiers in Pediatr"},{"key":"263_CR36","doi-asserted-by":"publisher","unstructured":"Fleming L, Knafl K, Knafl G, Van Riper M. Parental management of adrenal crisis in children with congenital adrenal hyperplasia. J Spec Pediatr Nurs. 2017. https:\/\/doi.org\/10.1111\/jspn.12190 .","DOI":"10.1111\/jspn.12190"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-018-0263-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-018-0263-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-018-0263-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T08:26:43Z","timestamp":1661416003000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-018-0263-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["263"],"URL":"https:\/\/doi.org\/10.1186\/s12902-018-0263-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"8 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was exempt from written informed consent due to its retrospective design. The study was approved by the local ethics committee of the Dept. Paediatrics of Erlangen and conducted upon approval of the German Society of Paediatric Endocrinology and Diabetology. The data was collected pseudonymously by a questionnaire and in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"37"}}